Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SSU72L5 (SSU72 RNA polymerase II CTD phosphatase homolog pseudogene 5) is annotated in genomic databases as a pseudogene related to the SSU72 phosphatase, an enzyme that regulates transcription by dephosphorylating the C-terminal domain of RNA polymerase II[1][2][3][4]. SSU72L5 does not encode a known functional protein product and no molecular functions, disease associations, or drug interactions have been documented. The similarity in naming to SSU72 may lead to confusion, but it should not be considered a functional protein, enzyme, or therapeutic target.\n\nIf you intended the canonical SSU72 (the serine-5 CTD phosphatase involved in RNA polymerase II regulation), please clarify; otherwise, SSU72L5 is a pseudogene and not a valid molecular target[3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SSU72 RNA polymerase II CTD phosphatase homolog pseudogene 5 (SSU72L5).